Table 1.
Baseline characteristics of young GC patients in the study.
| Variables | N (%) | |
| Patient-related | Number | 101 |
| Age (y) | ||
| Median | 26.0 | |
| Range | 17–30 | |
| Gender | ||
| Male | 48 (47.5) | |
| Female | 53 (52.5) | |
| Marital status | ||
| Married | 78 (77.2) | |
| Unmarried | 23 (22.8) | |
| Family history of tumor | ||
| Yes | 2 (2.0) | |
| No | 99 (98.0) | |
| Comorbidity | ||
| Yes | 6 (5.9) | |
| No | 95 (94.1) | |
| H.pylori | ||
| + | 7 (6.9) | |
| − | 80 (79.2) | |
| unknown | 14 (13.9) | |
| Fibrinogen (g/L) | ||
| Median | 3.13 | |
| Range | 1.45–17.6 | |
| Prealbumin (mg/L) | ||
| Median | 205.0 | |
| Range | 41.0–390.0 | |
| AFP (ng/mL) | ||
| Median | 2.65 | |
| Range | 0.5–219.86 | |
| CEA (ng/mL) | ||
| Median | 2.06 | |
| Range | 0.2–213.22 | |
| Tumor-related | Location | |
| Cardia | 7 (6.9) | |
| Body | 43 (42.5) | |
| Antrum | 44 (43.5) | |
| Cardia + Body + Antrum | 2 (2.0) | |
| Others | 5 (5.0) | |
| Tumor size (cm) | ||
| 0–2 | 12 (11.9) | |
| 2–5 | 41 (40.5) | |
| 5–7 | 24 (23.8) | |
| >7 | 24 (23.8) | |
| T stage | ||
| 1a | 4 (4.0) | |
| 1b | 3 (3.0) | |
| 2 | 15 (14.9) | |
| 3 | 18 (17.8) | |
| 4a | 46 (45.4) | |
| 4b | 15 (14.9) | |
| N stage | ||
| 0 | 29 (28.7) | |
| 1 | 47 (46.5) | |
| 2 | 19 (18.8) | |
| 3 | 6 (6.0) | |
| M stage | ||
| 0 | 80 (79.3) | |
| 1 | 31 (30.7) | |
| TNM | ||
| IA | 7 (6.9) | |
| IB | 4 (4.0) | |
| IIA | 11 (10.9) | |
| IIB | 17 (16.8) | |
| IIIA | 21 (20.8) | |
| IIIB | 7 (6.9) | |
| IIIC | 3 (3.0) | |
| IV | 31 (30.7) | |
| Differentiation of the tumor | ||
| Well differentiated | 10 (9.9) | |
| Moderately differentiated | 18 (17.8) | |
| Poorly differentiated | 73 (72.3) | |
| WHO type | ||
| adenocarcinoma | 67 (66.3) | |
| Signet ring | 7 (7.0) | |
| Adenocarcinoma & Signet ring | 18 (17.8) | |
| Others | 9 (8.9) | |
| Treatment-related | Surgical appoach | |
| Laparotomy | 38 (37.6) | |
| Laparoscope | 63 (62.4) | |
| Surgical treatment | ||
| Curative | 64 (63.4) | |
| Palliative | 37 (36.6) | |
| Treatment | ||
| Surgery | 35 (34.6) | |
| Surgery + chemotherapy | 64 (63.4) | |
| Lost to follow-up after surgery | 2 (2.0) |
AFP = alpha-fetoprotein, CEA = carcinoembryonic antigen, H.pylori = Helicobacter pylori.